Literature DB >> 7539744

Fusion of SYT to two genes, SSX1 and SSX2, encoding proteins with homology to the Kruppel-associated box in human synovial sarcoma.

A J Crew1, J Clark, C Fisher, S Gill, R Grimer, A Chand, J Shipley, B A Gusterson, C S Cooper.   

Abstract

We demonstrate that the cytogenetically defined translocation t(X;18)(p11.2;q11.2) found in human synovial sarcoma results in the fusion of the chromosome 18 SYT gene to either of two distinct genes, SSX1 or SSX2, at Xp11.2. The SSX1 and SSX2 genes encode closely related proteins (81% identity) of 188 amino acids that are rich in charged amino acids. The N-terminal portion of each SSX protein exhibits homology to the Kruppel-associated box (KRAB), a transcriptional repressor domain previously found only in Kruppel-type zinc finger proteins. PCR analysis demonstrates the presence of SYT-SSX1 or SYT-SSX2 fusion transcripts in 29 of 32 of the synovial sarcomas examined, indicating that the detection of these hybrid transcripts by PCR may represent a very useful diagnostic method. Sequence analysis has demonstrated heterogeneity in the fusion transcripts with the formation of two distinct SYT-SSX1 fusion junctions and two distinct SYT-SSX2 fusion junctions.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7539744      PMCID: PMC398342          DOI: 10.1002/j.1460-2075.1995.tb07228.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  40 in total

1.  The human tpr gene encodes a protein of 2094 amino acids that has extensive coiled-coil regions and an acidic C-terminal domain.

Authors:  P J Mitchell; C S Cooper
Journal:  Oncogene       Date:  1992-11       Impact factor: 9.867

2.  Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumours.

Authors:  O Delattre; J Zucman; B Plougastel; C Desmaze; T Melot; M Peter; H Kovar; I Joubert; P de Jong; G Rouleau
Journal:  Nature       Date:  1992-09-10       Impact factor: 49.962

3.  A consistent chromosome translocation in synovial sarcoma.

Authors:  S Smith; B R Reeves; L Wong; C Fisher
Journal:  Cancer Genet Cytogenet       Date:  1987-05

4.  Synovial sarcoma: ultrastructural and immunohistochemical features of epithelial differentiation in monophasic and biphasic tumors.

Authors:  C Fisher
Journal:  Hum Pathol       Date:  1986-10       Impact factor: 3.466

Review 5.  The molecular and genetic characterization of human soft tissue tumors.

Authors:  C S Cooper
Journal:  Adv Cancer Res       Date:  1993       Impact factor: 6.242

6.  Rearrangement of the PAX3 paired box gene in the paediatric solid tumour alveolar rhabdomyosarcoma.

Authors:  F G Barr; N Galili; J Holick; J A Biegel; G Rovera; B S Emanuel
Journal:  Nat Genet       Date:  1993-02       Impact factor: 38.330

Review 7.  Chromosomal translocations in human cancer.

Authors:  T H Rabbitts
Journal:  Nature       Date:  1994-11-10       Impact factor: 49.962

8.  Identification of a yeast artificial chromosome (YAC) spanning the synovial sarcoma-specific t(X;18)(p11.2;q11.2) breakpoint.

Authors:  B de Leeuw; W Berger; R J Sinke; R F Suijkerbuijk; S Gilgenkrantz; M T Geraghty; D Valle; A P Monaco; H Lehrach; H H Ropers
Journal:  Genes Chromosomes Cancer       Date:  1993-03       Impact factor: 5.006

9.  Localization of the synovial sarcoma t(X;18)(p11.2;q11.2) breakpoint by fluorescence in situ hybridization.

Authors:  J C Knight; B R Reeves; L Kearney; A P Monaco; H Lehrach; C S Cooper
Journal:  Hum Mol Genet       Date:  1992-11       Impact factor: 6.150

10.  Rearrangement of the transcription factor gene CHOP in myxoid liposarcomas with t(12;16)(q13;p11).

Authors:  P Aman; D Ron; N Mandahl; T Fioretos; S Heim; K Arheden; H Willén; A Rydholm; F Mitelman
Journal:  Genes Chromosomes Cancer       Date:  1992-11       Impact factor: 5.006

View more
  94 in total

1.  Gene expression studies on soft tissue tumors.

Authors:  Matt van de Rijn; Brian P Rubin
Journal:  Am J Pathol       Date:  2002-11       Impact factor: 4.307

2.  Analysis of transforming activity of human synovial sarcoma-associated chimeric protein SYT-SSX1 bound to chromatin remodeling factor hBRM/hSNF2 alpha.

Authors:  M Nagai; S Tanaka; M Tsuda; S Endo; H Kato; H Sonobe; A Minami; H Hiraga; H Nishihara; H Sawa; K Nagashima
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-27       Impact factor: 11.205

3.  t(X;18) reverse transcriptase-polymerase chain reaction demonstrating a variant transcript.

Authors:  Maureen J O'Sullivan; Peter A Humphrey; Louis P Dehner; John D Pfeifer
Journal:  J Mol Diagn       Date:  2002-08       Impact factor: 5.568

4.  PDGF receptor alpha is an alternative mediator of rapamycin-induced Akt activation: implications for combination targeted therapy of synovial sarcoma.

Authors:  Alan L Ho; Shyamprasad Deraje Vasudeva; Marick Laé; Tsuyoshi Saito; Violetta Barbashina; Cristina R Antonescu; Marc Ladanyi; Gary K Schwartz
Journal:  Cancer Res       Date:  2012-07-10       Impact factor: 12.701

5.  Malignant inguinal monophasic synovial sarcoma: report of a case and review of the literature.

Authors:  Ji Xu; Jia Wang; Long Cui; Xiangru Wu
Journal:  World J Surg Oncol       Date:  2010-11-21       Impact factor: 2.754

6.  Molecular basis of differentiation therapy for soft tissue sarcomas.

Authors:  Gaurav Luther; Richard Rames; Eric R Wagner; Gaohui Zhu; Qing Luo; Yang Bi; Stephanie H Kim; Jian-Li Gao; Enyi Huang; Ke Yang; Linyuan Wang; Xing Liu; Mi Li; Ning Hu; Yuxi Su; Xiaoji Luo; Liang Chen; Jinyong Luo; Rex C Haydon; Hue H Luu; Lan Zhou; Tong-Chuan He
Journal:  Trends Cancer Res       Date:  2010

7.  An immunodominant SSX-2-derived epitope recognized by CD4+ T cells in association with HLA-DR.

Authors:  Maha Ayyoub; Charles S Hesdorffer; Monica Montes; Andrea Merlo; Daniel Speiser; Donata Rimoldi; Jean-Charles Cerottini; Gerd Ritter; Matthew Scanlan; Lloyd J Old; Danila Valmori
Journal:  J Clin Invest       Date:  2004-04       Impact factor: 14.808

Review 8.  Synovial sarcoma: from genetics to genetic-based animal modeling.

Authors:  Malay Haldar; R Lor Randall; Mario R Capecchi
Journal:  Clin Orthop Relat Res       Date:  2008-06-18       Impact factor: 4.176

Review 9.  The SSX family of cancer-testis antigens as target proteins for tumor therapy.

Authors:  Heath A Smith; Douglas G McNeel
Journal:  Clin Dev Immunol       Date:  2010-10-11

10.  Loss of SS18-SSX1 inhibits viability and induces apoptosis in synovial sarcoma.

Authors:  Emily E Carmody Soni; Silke Schlottman; Hayriye V Erkizan; Aykut Uren; Jeffrey A Toretsky
Journal:  Clin Orthop Relat Res       Date:  2014-03       Impact factor: 4.176

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.